RXO, Inc.
RXO · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -929.46 | 1.05 | -0.52 | 0.42 |
| FCF Yield | -0.81% | 0.64% | -0.53% | -0.48% |
| EV / EBITDA | 129,669.33 | 118.22 | 1,939.12 | 568.56 |
| Quality | ||||
| ROIC | 0.00% | 0.36% | -0.98% | -0.74% |
| Gross Margin | 0.00% | 19.10% | 13.96% | 13.62% |
| Cash Conversion Ratio | -1.64 | -2.56 | 0.06 | 0.35 |
| Growth | ||||
| Revenue 3-Year CAGR | 13.44% | 9.53% | 4.10% | -1.74% |
| Free Cash Flow Growth | -223.41% | 199.95% | 10.53% | -5.56% |
| Safety | ||||
| Net Debt / EBITDA | 32.85 | 23.61 | 334.50 | 78.63 |
| Interest Coverage | 0.00 | 1.25 | -3.33 | -3.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 69.92 | 31.41 | 35.88 | 30.74 |